The results investigated the efficacy and safety of cabotegravir/rilpivirine, the company’s once-monthly injection for treating HIV.
15 March 2019 Comment
11 March 2019 News
The World Health Organization (WHO) has launched its Global Influenza Strategy for 2019-2030, its most comprehensive strategy to date against the infectious disease.
15 February 2019 Comment
GlobalData believes that the V920 vaccine is likely to be approved by the FDA this year and will establish a market-leading position in Ebola prevention.
14 February 2019 Comment
A respiratory syncytial virus is a common pneumovirus that causes seasonal lung and respiratory tract infections across the globe.
11 February 2019 News
Microbial therapies developer Finch Therapeutics has received breakthrough therapy designation from the US Food and Drug Administration (FDA) for its investigational CP101 drug to treat recurrent Clostridium difficile (C. difficile)...
5 February 2019 Comment
GlobalData believes these results should be treated with cautious optimism.
31 January 2019 News
UK Health and Social Care Secretary Matt Hancock has set a goal to end new HIV transmissions in the country by 2030 through improved prevention, detection and treatment of the...
24 January 2019 News
The UK Government has set out a plan to fight antimicrobial resistance (AMR) in the country by 2040, with an aim to cut down antibiotics use by 15% over the...
15 January 2019 News
Ascletis Pharma has signed an exclusive licensing agreement with Suzhou Alphamab to develop an investigational candidate, KN035, for the treatment of viral diseases such as hepatitis B in Greater China.